Last reviewed · How we verify

NCT03316755: RPPD

Risk Perception of Periodontal Disease

Completed NA Last updated 20 October 2017
What this trial tests

NA trial testing Exposure in Periodontal Diseases in 300 participants. Completed in 7 October 2017.

Timeline
1 March 2017
Primary endpoint
4 October 2017
7 October 2017

Quick facts

Lead sponsorUniversity of Benin
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment300
Start date1 March 2017
Primary completion4 October 2017
Estimated completion7 October 2017
Sites1 location across Nigeria

Drugs / interventions tested

Conditions studied

Sponsor

University of Benin

Who can join

Adults 16 to 60, any sex, with Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed at understanding the impact of educational pamphlet on Risk Perception of Periodontal Disease using A Randomised Clinical Trial model among patients in a Nigerian outpatient dental clinic

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exposure

Trials testing the same drug.

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other University of Benin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03316755.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing